WINKAST-AB TABLET
MRP: 2,350
Packaging: 10X10
Pack Type: tablet
Composition:
Montelukast Sodium IP Eqv. to Montelukast 10mg (In immediate release form) + Acebrophylline 200mg (In sustained release form)
Indication:
Used in the treatment of Chronic obstructive pulmonary disease (COPD) and Sneezing and runny nose due to allergies
Description:
This combination of Montelukast 10mg (IR) and Acebrophylline 200mg (SR) offers dual-action respiratory relief by targeting inflammation, bronchoconstriction, and mucus clearance. It is especially effective in managing asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, and chronic bronchitis.
Montelukast, a leukotriene receptor antagonist, reduces inflammation and bronchospasm, while Acebrophylline, a mucoregulator and bronchodilator, enhances mucus clearance and improves lung function over time.
Tags:
- Dual-action control for asthma and chronic bronchitis
- Reduces bronchial inflammation and constriction
- Aids mucus clearance and improves breathing
- Suitable for day and night symptom control
- Once-daily convenience due to sustained release
Usage Information
Dosage
Usual adult dose: 1 tablet once daily, preferably in the evening Swallow whole with water; do not crush or chew Follow dosage as per the physician’s advice
Side Effects
Nausea or stomach discomfort Dizziness or headache Dry mouth or throat irritation Allergic rash (rare) Sleep disturbances (rare with Montelukast)
Contraindications
Hypersensitivity to Montelukast or Acebrophylline Avoid in acute asthma attacks (not for emergency use) Caution in liver impairment, gastric ulcers, or epilepsy Consult a doctor before use in pregnancy or breastfeeding
Availability
Montelukast Acebrophylline tablets • Asthma treatment medicine • COPD mucolytic tablets • Bronchodilator and anti-allergic combo • Anti-asthmatic tablet